Healthcare -
Biotechnology - NASDAQ - US
$ 55.26
9.27 %
$ 4.36 B
Market Cap
-11.68
P/E
PTCT - REVENUE
Revenue PTCT - PTC Therapeutics, Inc.
938 M
LAST VALUE
31.96%
2 YEAR CAGR
28.78%
5 YEAR CAGR
40.48%
10 YEAR CAGR